Cosmetic ingredients maker United-Guardian's Q1 revenue and profit rise

United-Guardian

08/05/2026 14:15

Overview

U.S. specialty ingredients maker's Q1 revenue and net income rose yr/yr

Growth driven by higher pharmaceutical and cosmetic ingredient sales

Q1 income supplemented by settlement income from contract manufacturer shutdown in late 2023

Outlook

Company expects sales to continue increasing in 2026

Result Drivers

PHARMACEUTICAL SALES - Q1 pharmaceutical sales rose 24%, driven by increased demand for Renacidin

COSMETIC INGREDIENTS - Sales of cosmetic ingredients increased 21%, mainly due to a 45% rise in purchases by distributor ASI as it resumed regular buying after working off excess inventory

SETTLEMENT INCOME - Q1 net income was supplemented by settlement income related to a contract manufacturer shutdown in late 2023, which resulted in lost Renacidin sales

Company press release: ID:nGNX8k5TrH

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$2.87 mln
Q1 EPS
$0.18


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)